selected publications
-
academic article
- A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 32:1834-1846. 2019
- Regional Heterogeneity of D2-Receptor Signaling in the Dorsal Striatum and Nucleus Accumbens.. Neuron. 98:575-587.e4. 2018
- PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.. Journal of medical genetics. 53:800-811. 2016
- A targeted genetic association study of epithelial ovarian cancer susceptibility.. Oncotarget. 7:7381-7389. 2016
- Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer.. Cancer research. 74:3084-3091. 2014
- Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer.. BMC medical genomics. 7:-. 2014
- Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel.. Human molecular genetics. 22:3038-3047. 2013
- Assessment of hepatocyte growth factor in ovarian cancer mortality.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20:1638-1648. 2011
- No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.. Gynecologic oncology. -. 2015